Please wait while the formulary information is being retrieved.
ATROVENT HFA (IPRATROPIUM BROMIDE)
- Bronchospasm prevention with COPD
- Prevention of bronchospasms with emphysema
- Prevention of bronchospasm with chronic bronchitis
17 mcg/actuation aerosol inhaler
- Inhale 2 puffs (34 mcg) by inhalation route 4 times per day
Bronchospasm prevention with COPD
- Inhale 2 puffs (34 mcg) by inhalation route 4 times per day
Prevention of bronchospasm with chronic bronchitis
- Inhale 2 puffs (34 mcg) by inhalation route 4 times per day
Prevention of bronchospasms with emphysema
- Inhale 2 puffs (34 mcg) by inhalation route 4 times per day
- None
Contraindicated
- pramlintide
- Symlinpen 120
- Symlinpen 60
Severe
Moderate
- K-tab
- Klor-con
- Klor-con 10
- Klor-con M10
- Klor-con M15
- Klor-con M20
- Medi-lyte
- potassium chloride
- potassium citrate
- potassium Cl-calcium phos-mag
- sodium Cl-potassium chloride
- Thermotabs
- Urocit-k 10
- Urocit-k 15
- Urocit-k 5
- None
Contraindicated
- None
Severe
Moderate
- Angle-closure glaucoma
- Benign prostatic hyperplasia
- Bladder outflow obstruction
- Urinary retention
ATROVENT HFA (IPRATROPIUM BROMIDE)
- Bronchospasm prevention with COPD
- Prevention of bronchospasms with emphysema
- Prevention of bronchospasm with chronic bronchitis
- None
- Dry throat
- Dyspnea
- Flu-like symptoms
- Upper respiratory infection
More Frequent
Severe
Less Severe
- Paradoxical bronchospasm
- Bronchitis
- Chest pain
- Constipation
- Cough
- Diarrhea
- Dizziness
- Dyspepsia
- Headache disorder
- Rhinitis
- Sinusitis
- Urinary tract infection
- Xerostomia
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Aggravated glaucoma
- Anaphylaxis
- Angioedema
- Hypokalemia
- Ocular pain
- Pharyngeal edema
- Pruritus of skin
- Skin rash
- Stomatitis
- Urticaria
Less Severe
- Blurred vision
- Conjunctival hyperemia
- Corneal edema
- Drowsy
- Dysgeusia
- Edema
- Flushing
- General weakness
- Heartburn
- Hoarseness
- Hyperhidrosis
- Hypotension
- Laryngismus
- Muscle spasm
- Muscle weakness
- Myalgias
- Mydriasis
- Nasal congestion
- Nausea
- Ocular hypertension
- Palpitations
- Urinary retention
- Visual changes
- Vomiting
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Ipratropium (HFA)
Limited safety and efficacy data. Risk of dizziness, headache, anxiety, GI discomfort, cough.
- 1 Day – 18 Years
- Limited safety and efficacy data. Risk of dizziness, headache, anxiety, GI discomfort, cough.
Ipratropium Bromide
- Severity Level:
B
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Ipratropium Bromide
Unlikely clinically significant amount excreted with inhal/nasal admin
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Unlikely clinically significant amount excreted with inhal/nasal admin |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Ipratropium Bromide
Urogenital-Use caution in men with benign prostatic hyperplasia; may decrease urinary flow and cause urinary retention. Other-Use caution in elderly with narrow angle glaucoma. Gastrointestinal-Anticholinergic effects may worsen constipation in predisposed elderly.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | N | N | N | N | N | N |
BEERS: N HEDIS: N STOPP: Y
No Known Risk
None
- None
| Bronchospasm prevention with COPD | |
| J44 | Other chronic obstructive pulmonary disease |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| Prevention of bronchospasm with chronic bronchitis | |
| J41 | Simple and mucopurulent chronic bronchitis |
| J41.0 | Simple chronic bronchitis |
| J41.1 | Mucopurulent chronic bronchitis |
| J41.8 | Mixed simple and mucopurulent chronic bronchitis |
| J42 | Unspecified chronic bronchitis |
| J44 | Other chronic obstructive pulmonary disease |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| Prevention of bronchospasms with emphysema | |
| J43 | Emphysema |
| J43.0 | Unilateral pulmonary emphysema [macleod's syndrome] |
| J43.1 | Panlobular emphysema |
| J43.2 | Centrilobular emphysema |
| J43.8 | Other emphysema |
| J43.9 | Emphysema, unspecified |
| J44 | Other chronic obstructive pulmonary disease |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| 0-9 | A-Z |
|---|---|
| J41 | Simple and mucopurulent chronic bronchitis |
| J41.0 | Simple chronic bronchitis |
| J41.1 | Mucopurulent chronic bronchitis |
| J41.8 | Mixed simple and mucopurulent chronic bronchitis |
| J42 | Unspecified chronic bronchitis |
| J43 | Emphysema |
| J43.0 | Unilateral pulmonary emphysema [macleod's syndrome] |
| J43.1 | Panlobular emphysema |
| J43.2 | Centrilobular emphysema |
| J43.8 | Other emphysema |
| J43.9 | Emphysema, unspecified |
| J44 | Other chronic obstructive pulmonary disease |
| J44 | Other chronic obstructive pulmonary disease |
| J44 | Other chronic obstructive pulmonary disease |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
Formulary Reference Tool